Reply to: "Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries"-MedSci.cn

Reply to: "Response to DAA therapy in the NHS England Early Access Programme for rare HCV subtypes from low and middle income countries"

Zeuzem, S; Dvory-Sobol, H; Brainard, DM

Zeuzem, S (reprint author), Johann Wolfgang Goethe Univ Med Ctr, Theodor Stern Kai 7, D-60590 Frankfurt, Germany.

JOURNAL OF HEPATOLOGY, 2017; 67 (6): 1350

科室
- - 订阅+
  - 更多科室
工具
服务